News / Business
Hospira Inc (NYSE:HSP) to Hold Q4 2008 Earnings Conference Call February 17
Hospira, Inc. (Hospira) is a specialty pharmaceutical and medication delivery company. Hospira is engaged in the development, manufacture and marketing of specialty injectable pharmaceuticals and medication delivery systems that deliver drugs and intravenous (I.V.) fluids. Hospira is also a provider of contract manufacturing services to pharmaceutical and biotechnology companies for formulation development, filling and finishing of injectable pharmaceuticals. Hospira’s portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. During the year ended December 31, 2007, the Company’s sales in United States accounted for approximately 69% and sales outside the United States accounted for the remaining 31% of its total sales. In October 2008, the Company acquired EndoTool business from MD Scientific, LLC.
Click here for more Business News
About The Global Market Directory (TheGMD)
TheGMD provides an online global directory listing featuring public companies,
stock brokers, brokerage firms and individuals. The GMD provides
profiles for Brokerage Firms, Stock Brokers and Individuals in addition
to Public Companies.
The
GMD is a division of TransWorldNews, Inc. Companies can utilize the
TransWorldNews press release distribution services and have all news
releases attached to their GMD profile.
